StonvexLoading…
StonvexStonvexStonvexCore line items from RSKIA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-01-31 | Q4 2025 2025-10-31 | Q3 2025 2025-07-31 | Annual 2025 2025-04-30 |
|---|---|---|---|---|
Revenue | $17.89M | $12.23M | $5.90M | $22.54M |
Operating Income | $4.91M | $3.59M | $1.81M | $6.24M |
Net Income | $8.62M | $6.13M | $3.79M | $7.13M |
EPS (Diluted) | $1.75 | $1.25 | $0.77 | $1.45 |
Total Assets | $68.36M | $66.18M | $68.21M | $63.34M |
Total Liabilities | $7.68M | $7.94M | $7.57M | $6.48M |
Cash & Equivalents | $4.46M | $4.84M | $8.26M | $6.47M |
Free Cash Flow OCF − CapEx | $3.45M | $3.19M | $2.01M | $3.91M |
Shares Outstanding | 8.50M | 8.50M | 8.50M | 8.50M |